Drawing for ZEPTO

USPTO serial 76236175

ZEPTO

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
AWRICH, ELLEN
Law office
DIVISIONAL UNIT

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ZEPTO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

WILLIAM B. RITCHIE

MARK A WRIGHT ESQ MCLANE, GRAF, RAULERSON & MIDDLETONPO BOX 326MANCHESTER, NH 03105-0326UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals and chemical compositions for measuring molecular interactions for use in research and development in industry, science as well as in agriculture, horticulture and forestry, namely diagnostic agents and test kits for homogeneous and heterogeneous assays comprising functionalized surfaces, chemical, biological and biochemical compounds as recognition elements, enzymes, labeling compounds, assay reagents, washing reagents and calibration solutionsACTIVE
009Laboratory apparatus and bioanalytical appliances comprising fluidic instruments for separation and mass spectrometric technologies; sensitized biochips and bioreactive surfaces, chemical and biochemical sensors, biochips containing nucleic acid, protein and receptor microarrays, and micro fluidic cell or biochip cartridges in nucleic acid and proteomic research; laboratory apparatus and instruments, comprising fluidic instruments and optical exciters and detectors, for the production and quality control of sensitized biochips and bioreactive surfaces containing chemical and biochemical sensors, nucleic acid, protein and receptor microarrays; spectrometers and optical scanners; optical exciters and detectors for biochips; photodiodes and photodiode arrays; photomultipliers; photographic cameras; video cameras; Charge-Coupled Device (CCD) cameras, namely, cameras employing a light-sensitive silicon chip for the detection and collection of optical signals from biochips; imaging systems comprising cameras and computers and exposure controls for use with photodiode arrays; photomultipliers, photographic cameras, video and CCD cameras for the detection and collection of optical signals from biochips; manually operated and automated sample preparation, assay and hybridization stations for the conditioning, probe introduction and automation of wash and assay cycles for the probe binding to microarrays in nucleic acid and proteomic research; computer software containing algorithms for identifying, filtering, quantifying and analyzing data from biochip images and controlling and automating the production, identification, assaying, imaging and analysis of biochips; computer software for study design, namely, design of experimental conditions, biochip design, namely, choice of recognition elements and their geometrical deposition on a biochip, assay design, namely, design of assay architecture and conditions, and data analysis from biochip images; computer software for the generation of databases and libraries, input of biochip data into databases and libraries, and interfacing with external databases and libraries for the correlation of analytical data with results from biological or pharmacological studies; computer monitors, printers and keypads for the display of biochip images; computer hard drives, disk drives and CD ROM drives for the storage of analytical biochip data into databases and libraries for correlation with results from biological or pharmacological studiesACTIVE
040Manufacture of biochips to the order and/or specification of othersACTIVE
042Laboratory research and development services in the field of bioanalytics, namely the development of pharmaceutical, medical, forensic, veterinary and agricultural chemicals and biochemicals, genomic and proteomic analysis, assaying, imaging and profiling, chemical screening analysis, and genetic medical testing services, biochip design and analysis services in the field of biotechnology; computer programming services in the fields of biotechnology and biochemistry, namely microarray designs for nucleic acid and protein structural analysis, imaging data analysis, generation of databases and libraries, input of biochip data into databases and libraries, and interfacing with external databases and libraries for the correlation of analytical data with results from biological or pharmaceutical studiesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 10, 2005MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 10, 2005ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 31, 2004EX2GSOU EXTENSION 2 GRANTED
Aug 18, 2004EXT2SOU EXTENSION 2 FILED
Aug 18, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 13, 2004CFITCASE FILE IN TICRS
Mar 8, 2004EX1GSOU EXTENSION 1 GRANTED
Feb 25, 2004EXT1SOU EXTENSION 1 FILED
Feb 25, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 26, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 19, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 2, 2002ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
May 28, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 8, 2002NPUBNOTICE OF PUBLICATION
Apr 8, 2002MAILPAPER RECEIVED
Jan 14, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 21, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 25, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 23, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 26, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 19, 2001DOCKASSIGNED TO EXAMINER
Jul 16, 2001DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance